Ads
related to: latest treatment for metastatic melanoma
Search results
Results from the WOW.Com Content Network
Darovasertib is an investigational new drug that is being evaluated for the treatment of metastatic uveal melanoma and other cancers. It is a first-in-class oral, small molecule inhibitor of protein kinase C (PKC). [1] [2]
A new therapy for metastatic melanoma was shown to be more effective than a leading immunotherapy for the skin cancer. Skip to main content. 24/7 Help. For premium support please call: 800-290 ...
On February 1, 2012, Health Canada approved ipilimumab for "treatment of unresectable or metastatic melanoma in patients who have failed or do not tolerate other systemic therapy for advanced disease." [24] Ipilimumab was approved in the European Union (EU), for second line treatment of metastatic melanoma in November 2012. [25] [26]
IL-2 was the first new therapy approved (1990 EU, 1992 US) for the treatment of metastatic melanoma in 20 years. [139] IL-2 may offer the possibility of a complete and long-lasting remission in this disease in a small percentage of people with melanoma. [ 140 ]
A huge advancement in cancer treatment after the Food and Drug Administration just approved a type of cell therapy for patients with late-stage melanoma.
Micrograph showing a PD-L1 positive non-small cell lung carcinoma. PD-L1 immunostain. As of 2019, pembrolizumab is used via intravenous infusion to treat inoperable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC) in certain situations, as a first-line treatment for metastatic bladder cancer in patients who cannot receive cisplatin-based chemotherapy and have high levels ...
Ads
related to: latest treatment for metastatic melanoma